Menora Mivtachim Holdings’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Menora Mivtachim Holdings’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$319K	Sell	2,500 -2,500	-50%	-$312K	﹤0.01%	148
2025 Q4	$610K	Hold	5,000	–	–	﹤0.01%	118
2025 Q3	$501K	Hold	5,000	–	–	﹤0.01%	118
2025 Q2	$415K	Hold	5,000	–	–	﹤0.01%	117
2025 Q1	$406K	Hold	5,000	–	–	﹤0.01%	112
2024 Q4	$450K	Sell	5,000 -500	-9%	-$48.4K	﹤0.01%	88
2024 Q3	$543K	Buy	+5,500	New	+$540K	﹤0.01%	82
2024 Q1	–	Sell	-4,000	Closed	-$357K	–	99
2023 Q4	$357K	Hold	4,000	–	–	﹤0.01%	90
2023 Q3	$292K	Buy	+4,000	New	+$320K	﹤0.01%	90

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Menora Mivtachim Holdings's XBI Position: Q1 2026 in Review

Menora Mivtachim Holdings reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 50% in Q1 2026, selling an estimated $312K and leaving 2,500 shares worth $319K. The position accounts for ﹤0.01% of the portfolio, ranked #148.

Menora Mivtachim Holdings first reported a position in XBI in Q3 2023 and has held it in 9 quarters since. The position peaked at $610K in Q4 2025. 814 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

Menora Mivtachim Holdings held 2,500 shares of State Street SPDR S&P Biotech ETF worth $319K as of Q1 2026.
Menora Mivtachim Holdings sold 2,500 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $312K.
State Street SPDR S&P Biotech ETF made up ﹤0.01% of Menora Mivtachim Holdings's portfolio in Q1 2026, its #148 holding.
Menora Mivtachim Holdings first reported a position in State Street SPDR S&P Biotech ETF in Q3 2023 and has held it in 9 quarters since.
Menora Mivtachim Holdings's State Street SPDR S&P Biotech ETF position peaked at $610K in Q4 2025.
814 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Menora Mivtachim Holdings's 13F filing for Q1 2026, filed 14 May 2026.